Inactive Instrument
Peloton Therapeutics, Inc. Stock
Stocks
PLTX
US70614L1044
Biotechnology & Medical Research
| Manager | Title | Age | Since |
|---|---|---|---|
Dalton Smart
PSD | President | - | - |
Peter Stenge
PRN | Corporate Officer/Principal | - | - |
| Corporate Officer/Principal | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Brett A. Ringle
BRD | Director/Board Member | 75 | 2011-07-27 |
Helen Kim
BRD | Director/Board Member | 63 | 2017-10-31 |
David Chang
BRD | Director/Board Member | 66 | 2018-01-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 711M | |
| +0.06% | +6.49% | +60.29% | +111.13% | 74.27B | |
| -2.29% | -1.51% | +33.30% | +75.07% | 61.21B | |
| -2.05% | -3.46% | -18.60% | +352.20% | 26.38B | |
| -2.39% | +2.74% | +0.19% | -5.91% | 25.34B | |
| +0.57% | +3.66% | +25.59% | -9.37% | 20.84B | |
| +1.29% | -2.49% | +152.11% | +333.06% | 15.17B | |
| -2.44% | -0.09% | +42.50% | +164.11% | 14.41B | |
| -3.91% | -4.91% | -14.10% | +779.68% | 13.66B | |
| -1.12% | -3.04% | +15.72% | +234.56% | 11.99B | |
| Average | -1.23% | +0.03% | +33.00% | +226.06% | 29.25B | |
| Weighted average by Cap. | -1.22% | +1.01% | +36.01% | +162.09% |
Employees
64
